These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 18020905)

  • 1. Effect of angiogenesis-related cytokines on rotator cuff disease: the search for sensitive biomarkers of early tendon degeneration.
    Savitskaya YA; Izaguirre A; Sierra L; Perez F; Cruz F; Villalobos E; Almazan A; Ibarra C
    Clin Med Insights Arthritis Musculoskelet Disord; 2011; 4():43-53. PubMed ID: 21792342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers: a valuable tool in clinical research and medical practice.
    Carini C
    IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational research in the pharmaceutical industry: from bench to bedside.
    O'Connell D; Roblin D
    Drug Discov Today; 2006 Sep; 11(17-18):833-8. PubMed ID: 16935752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Biomarkers Forum: harnessing the potential of biomarkers from translational research throughout clinical trials.
    Shaw M
    Expert Rev Mol Diagn; 2007 Nov; 7(6):759-60. PubMed ID: 18020905
    [No Abstract]   [Full Text] [Related]  

  • 5. Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development.
    Park JW; Kerbel RS; Kelloff GJ; Barrett JC; Chabner BA; Parkinson DR; Peck J; Ruddon RW; Sigman CC; Slamon DJ
    Clin Cancer Res; 2004 Jun; 10(11):3885-96. PubMed ID: 15173098
    [No Abstract]   [Full Text] [Related]  

  • 6. Driving earlier clinical attrition: if you want to find the needle, burn down the haystack. Considerations for biomarker development.
    Peck RW
    Drug Discov Today; 2007 Apr; 12(7-8):289-94. PubMed ID: 17395088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for TB treatment response: challenges and future strategies.
    Walzl G; Ronacher K; Djoba Siawaya JF; Dockrell HM
    J Infect; 2008 Aug; 57(2):103-9. PubMed ID: 18649943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A generic operational strategy to qualify translational safety biomarkers.
    Matheis K; Laurie D; Andriamandroso C; Arber N; Badimon L; Benain X; Bendjama K; Clavier I; Colman P; Firat H; Goepfert J; Hall S; Joos T; Kraus S; Kretschmer A; Merz M; Padro T; Planatscher H; Rossi A; Schneiderhan-Marra N; Schuppe-Koistinen I; Thomann P; Vidal JM; Molac B
    Drug Discov Today; 2011 Jul; 16(13-14):600-8. PubMed ID: 21570476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational dermatology in drug discovery: perspectives for integrating humanized xenograft models and experimental clinical studies.
    Petersen TK; Sørensen P
    Drug Discov Today; 2008 Mar; 13(5-6):240-6. PubMed ID: 18342800
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.